Stranger in a strange land

Immunological Reviews

Volumn 213, Issue 1, 2006, Pages 36-47

  Hunt, Joan S ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

HLA G; Immune privilege; Pregnancy; Trophoblast

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA E ANTIGEN; HLA F ANTIGEN; HLA G ANTIGEN; ISOPROTEIN; LEUKOCYTE ANTIGEN; PROTEIN;

ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; EMBRYO DEVELOPMENT; EMBRYO GROWTH; FETUS (ANATOMY); FETUS CIRCULATION; FETUS DEVELOPMENT; FETUS WASTAGE; GENE EXPRESSION; GENE FUNCTION; GRAFT REJECTION; HISTOCOMPATIBILITY COMPLEX; HISTOCOMPATIBILITY GENE; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOGENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MATERNAL BLOOD; MATERNAL CARE; MOLECULAR BIOLOGY; MOTHER FETUS RELATIONSHIP; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA; PREGNANCY; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TARGET CELL; TROPHOBLAST; UTERUS;

ANIMALS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; PREGNANCY; TROPHOBLASTS;

EID: 33748755427     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2006.00436.x     Document Type: Review

References (77)

1. Heinlein RA. Stranger in a Strange Land. New York: GP Putnam's Sons, 1961.
2. Burton GJ, Hempstock J, Jauniaux E. Oxygen, early embryonic metabolism and free radical-mediated embryopathies. Reprod Biomed Online 2002;6:84-96.
3. Bulmer JN, Pace D, Ritson A. Immunoregulatory cells in human decidua: morphology, immunohistochemistry and function. Reprod Nutr Dev 1988;28:1599-1613.
4. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet 2001;2:538-548.
5. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 2005;19:681-693.
6. Hunt JS, McIntire RH, Petroff MG. Immunobiology of human pregnancy. In: Neill JD, ed. Knobil and Neill's Physiology of Reproduction, Vol. 2, 3rd edn. St Louis: Elsevier/Academic Press, 2006:2759-2785.
7. Hunt JS. Major histocompatibility antigens in reproduction. In: Glasser S., Alpin J, Guidice L, Tabibzadeh S, eds. The Endometrium. London and New York: Taylor & Francis, 2002:405-415.
8. McMaster MT, Newton RC, Dey SK, Andrews GK. Activation and distribution of inflammatory cells in the mouse uterus during the preimplantation period. J Immunol 1992;148:1699-1705.
9. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002;2:656-663.
10. Croy BA, et al. Uterine natural killer cells: insights into their cellular and molecular biology from mouse modeling. Reproduction 2003;126:149-160.
11. Heikkinen J, Mottonen M, Alanen A, Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol 2004;136:373-378.
12. Wu X, Jin LP, Yuan MM, Zhu Y, Wang MY, Li DJ. Human first-trimester trophoblast cells recruit CD56brightCD16- NK cells into decidua by way of expressing and secreting of CXCL12/stromal cell-derived factor-1. J Immunol 2005;175:61-68.
13. Fournel S, et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000;164:6100-6104.
14. Morales PJ, et al. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol 2003;171:6215-6224.
15. Lysiak JJ, Hunt J, Pringle GA, Lala PK. Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta 1995;16:221-231.
16. McIntire RH, Morales PJ, Petroff MG, Colonna M, Hunt JS. Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-{beta}1. J Leukoc Biol 2004;76:1220-1228.
17. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993;14:353-356.
18. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H. A critical role for murine complement regulatory crry in fetomaternal tolerance. Science 2000;287:498-501.
19. Baban B, Chandler P, McCool D, Marshall B, Munn DH, Mellor AL. Indoleamine 2, 3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J Reprod Immunol 2004;61:67-77.
20. Ober C, et al. HLA-G1 protein expression is not essential for fetal survival. Placenta 1998;19:127-132.
21. Cao W, Brenner CA, Alikani M, Cohen J, Warner CM. Search for a human homologue of the mouse Ped gene. Mol Hum Reprod 1999;5:541-547.
22. Langat DK, Morales PJ, Fazleabas AT, Mwenda JM, Hunt JS. The olive baboon (Papio anubis): a potential animal model to study the function of human leukocyte antigen-G (HLA-G). Gynecol Obstet Invest 2004;57:33-36.
23. Langat DK, Morales PJ, Fazleabas AT, Mwenda JM, Hunt JS. Potential regulatory sequences in the untranslated regions of the baboon MHC class Ib gene, Paan-AG, more closely resemble those in the human MHC class Ia genes than those in the class Ib gene, HLA-G. Immunogenetics 2004;56:657-666.
24. Phillips TA, Ni J, Hunt JS. Death-inducing tumor necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentas, cytotrophoblasts, placental macrophages and placental cell lines. Placenta 2001;22:663-672.
25. Hunt JS, Chen HL, Miller L. Tumor necrosis factors: pivotal factors in pregnancy? Biol Reprod 1996;54:554-562.
26. Phillips TA, Ni J, Pan G, Ruben SM, Wei YF, Hunt JS. TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for tumor protection and immune privilege. J Immunol 1999;162:6053-6059.
27. Hunt JS, Vassmer D, Ferguson TA, Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 1997;158:4122-4128.
28. Kauma SW, Huff TF, Hayes N, Nilkaeo A. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J Clin Endocrinol Metab 1999;84:2188-2194.
29. Hiby SE, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004;200:957-965.
30. Grimsley C, Ober C. Population genetic studies of HLA-E: evidence for selection. Hum Immunol 1997;52:33-40.
31. Ober C, Aldrich CL. HLA-G polymorphisms: neutral evolution or novel function? J Reprod Immunol 1997;36:1-21.
32. Hunt JS, Orr HT. HLA and maternal-fetal recognition. FASEB J 1992;6:2344-2348.
33. Le Bouteiller P, Mallet V. HLA-G and pregnancy. Rev Reprod 1997;2:7-13.
34. Suárez MB, et al. A new HLA-G allele (HLAG* 0105N) and its distribution in the Spanish population. Immunogenetics 1997;45:464-465.
35. Menier C, Riteau B, Dausset J, Carosella ED, Rouas-Freiss N. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. Hum Immunol 2000;61:1118-1125.
36. Aldrich CL, et al. HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod 2001;7:1162-1172.
37. Pfeiffer KA, Fimmers R, Engels G, van Der Ven H, van Der Ven K. The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol Hum Reprod 2001;7:373-378.
38. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003;55:63-79.
39. Goldman-Wohl DS, et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 2000;6:88-95.
40. Lim KH, et al. Human cytotrophoblast differentiation/invasion is abnormal in preeclampsia. Am J Pathol 1997;151:1809-1818.
41. Aldrich C, Verp MS, Walker MA, Ober C. A null mutation in HLA-G is not associated with preeclampsia or intrauterine growth retardation. J Reprod Immunol 2000;47:41-48.
42. O'Brien M, et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 2001;58:1943-1949.
43. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592-1594.
44. Hviid TV, et al. Characterization of a new HLA-G allele encoding a nonconservative amino acid substitution in the alpha3 domain (exon 4) and its relevance to certain complications in pregnancy. Immunogenetics 2001;53:48-53.
45. Harrison GA, Humphrey KE, Jakobsen IB, Cooper DW. A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet 1993;2:2200.
46. Hiby SE, King A, Sharkey A, Loke YW. Molecular studies of trophoblast HLA-G: polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue Antigens 1999;53:1-13.
47. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences HLAG mRNA stability. Hum Immunol 2003;64:1005-1010.
48. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003;5:63-79.
49. Aldrich C, Verp MS, Walker MA, Ober C. A null mutation in HLA-G is not associated with preeclampsia or intrauterine growth retardation. J Reprod Immunol 2000;47:41-48.
50. Hviid TV, Sorensen S, Morling N. Polymorphism in the regulatory region located more than 1.1 kilobases 5′ to the start site of transcription, the promoter region, and exon 1 of the HLA-G gene. Hum Immunol 1999;60:1237-1244.
51. Ober C, et al. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003;72:1425-1435.
52. Ober C, Billstrand C, Kuldanek S, Tan Z. The miscarriage-associated HLA-G -725 allele influences transcription rates in JEG-3 cells. Hum Reprod 2006;21:1743-1748.
53. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Nat Acad Sci U S A 1992;89:3947-3951.
54. Soares MJ. The prolactin and growth hormone families: pregnancy-specific hormones/cytokines at the maternal-fetal interface. Reprod Biol Endocrinol 2004;2:51.
55. Le Bouteiller P. Human villous trophoblast and the lack of intron 4-retaining soluble HLA-G secretion: beware of possible methodological biases. Mol Hum Reprod 2005;11:711-713.
56. Hunt JS, Geraghty DE. Soluble HLA-G isoforms, HLA-G5 and HLA-G6: technical deficiencies lead to misinterpretations. Mol Hum Reprod 2005;11:715-717.
57. Ishitani A, et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003;171:1376-1384.
58. Gonen-Gross T, et al. The CD84J/leukocyte inhibitory receptor-2 distinguishes between conformed and β2-microglobulin-free HLA-G molecules. J Immunol 2005;175:4866-4874.
59. Hunt JS, Jadhav L, Chu W, Geraghty DE, Ober C. Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000;183:682-688.
60. Yao YQ, Barlow DH, Sargent IL. Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses. J Immunol 2005;175:8379-8385.
61. Hunt JS, Pace JL, Morales PJ, Ober C. Immunogenicity of the soluble isoforms of HLA-G. Mol Hum Reprod 2003;9:729-735.
62. Lee N, et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A 1998;95:5199-5204.
63. Wooden SL, Kalb SR, Cotter RJ, Soloski MJ. Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis. J Immunol 2005;175:1383-1387.
64. Ishitani A, Sageshima N, Hatake K. The involvement of HLA-E and -F in pregnancy. J Reprod Immunol 2006;69:101-113.
65. Allan DS, McMichael AJ, Braud VM. The ILT family of leukocyte receptors. Immunobiology 2000;202:34-41.
66. Brown D, Trowsdale J, Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 2004;64:215-225.
67. Yang Y, Geraghty DE, Hunt JS. Cytokine regulation of HLA-G expression in human trophoblast cell lines. J Reprod Immunol 1995;29:179-195.
68. Hunt JS, Langat D, McIntire RH, Morales P. The role of HLA-G in human pregnancy. Reprod Biol Endocrinol (in press).
69. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006;24:99-146.
70. Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? Cancer Res 2005;65:10139-10144.
71. Kemper C, Verbsky JW, Price JD, Atkinson JP. T-cell stimulation and regulation: with complements from CD46. Immunol Res 2005;32:31-44.
72. Ragusa A, et al. Progesterone supplement in pregnancy: an immunologic therapy? Lupus 2004;13:639-642.
73. Hunt JS, Miller L, Platt JS. Hormonal regulation of uterine macrophages. Dev Immunol 1998;6:105-110.
74. Slukvin II, Lunn DP, Watkins DI, Golos TG. Placental expression of the nonclassical MHC class I molecule Mamu-AG at implantation in the rhesus monkey. Proc Natl Acad Sci U S A 2000;97:9104-9109.
75. Baban B, Chandler P, McCool D, Marshall B, Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J Reprod Immunol 2004;61:67-77.
76. Lien E, Liabakk NB, Austgulen R. Detection of soluble receptors for tumor necrosis factor, interleukin-2 and interleukin-6 in retroplacental serum from normal pregnant women. Gynecol Obstet Invest 1996;41:1-4.
77. Petroff MG, Chen L, Phillips TA, Azzola D, Sedlmayr P, Hunt JS. B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol Reprod 2003;68:1496-1504.